Comparison of methods for evaluating drug-drug interaction. - Wikidata - wikimedia - TriplyDB

Comparison of methods for evaluating drug-drug interaction.

Comparison of methods for evaluating drug-drug interaction.

http://www.wikidata.org/entity/Q33914266

about

Computer-based identification of a novel LIMK1/2 inhibitor that synergizes with salirasib to destabilize the actin cytoskeleton What is synergy? The Saariselkä agreement revisited Live-cell microscopy reveals small molecule inhibitor effects on MAPK pathway dynamics A quinoxaline derivative as a potent chemotherapeutic agent, alone or in combination with benznidazole, against Trypanosoma cruzi In-depth analysis shows synergy between erlotinib and miR-34a Halofuginone Synergistically Enhances Anti-Proliferation of Rapamycin in T Cells and Reduces Cytotoxicity of Cyclosporine in Cultured Renal Tubular Epithelial Cells The Comparison of MTT and CVS Assays for the Assessment of Anticancer Agent Interactions Actions of sesquiterpene lactones isolated from Moquiniastrum polymorphum subsp. floccosum in MCF7 cell line and their potentiating action on doxorubicin An ex vivo assay of XRT-induced Rad51 foci formation predicts response to PARP-inhibition in ovarian cancer Vorinostat synergizes with ridaforolimus and abrogates the ridaforolimus-induced activation of AKT in synovial sarcoma cells.Effect of sulfasalazine on human neuroblastoma: analysis of sepiapterin reductase (SPR) as a new therapeutic target.Paclitaxel improved anti-L1CAM lutetium-177 radioimmunotherapy in an ovarian cancer xenograft model.Combined inhibition of MEK and mTOR has a synergic effect on angiosarcoma tumorgrafts Gonadotropin-mediated chemoresistance: Delineation of molecular pathways and targets The Combination of Vitamin K3 and Vitamin C Has Synergic Activity against Forms of Trypanosoma cruzi through a Redox Imbalance Process.Cytotoxicity enhancement in MDA-MB-231 cells by the combination treatment of tetrahydropalmatine and berberine derived from Corydalis yanhusuo W. T. Wang.Interactions of everolimus and sorafenib in pancreatic cancer cells.An Integrative Pharmacogenomic Approach Identifies Two-drug Combination Therapies for Personalized Cancer Medicine.Decursin and Doxorubicin Are in Synergy for the Induction of Apoptosis via STAT3 and/or mTOR Pathways in Human Multiple Myeloma Cells.Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas Disease Analyses of the combination of 6-MP and dasatinib in cell culture Comparative drug pair screening across multiple glioblastoma cell lines reveals novel drug-drug interactions Benzyl isothiocyanate inhibits HNSCC cell migration and invasion, and sensitizes HNSCC cells to cisplatin.Transactivation of bad by vorinostat-induced acetylated p53 enhances doxorubicin-induced cytotoxicity in cervical cancer cells.Induction of Early Autophagic Process on Leishmania amazonensis by Synergistic Effect of Miltefosine and Innovative Semi-synthetic Thiosemicarbazone.Synergistic effects of floral phytochemicals against a bumble bee parasite.Inhibitors of GLUT/SLC2A Enhance the Action of BCNU and Temozolomide against High-Grade Gliomas.Analysis of drug combinations: current methodological landscape.Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.Method to Assess Interactivity of Drugs with Nonparallel Concentration-Effect Relationships.Synergistic co-targeting of prostate-specific membrane antigen and androgen receptor in prostate cancer.Adrenomedullin blockade suppresses sunitinib-resistant renal cell carcinoma growth by targeting the ERK/MAPK pathway.Roles of ceramide synthase and ceramide clearence genes in nilotinib-induced cell death in chronic myeloid leukemia cells.A novel mechanism of dasatinib-induced apoptosis in chronic myeloid leukemia; ceramide synthase and ceramide clearance genes.Chemical Genomics Approach Leads to the Identification of Hesperadin, an Aurora B Kinase Inhibitor, as a Broad-Spectrum Influenza Antiviral.Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses.Combination effect of therapies targeting the PI3K- and AR-signaling pathways in prostate cancer.Effects of (1E,4E)-2-Methyl-1,5-bis(4-nitrophenyl)penta-1,4-dien-3-one on Trypanosoma cruzi and Its Combinational Effect with Benznidazole, Ketoconazole, or Fluconazole.Nonlinear response surface in the study of interaction analysis of three combination drugs.Modulation of antibiotic resistance in Pseudomonas aeruginosa by ZnO nanoparticles.

P2860

Q24600408-60463B24-2ECF-40F1-B331-B3BA43C37125 Q26782977-9EFA1D65-459C-4BCD-91EE-34D83F885955 Q28476446-B074C5E0-6AD4-4AF0-AECD-5E08082308D8 Q28538813-98E2F1AF-D851-4F2E-8E9B-7D40D8AB06D7 Q28539851-B916DF5B-3722-4545-805B-F7DF4EEC1AEB Q28551630-09C73C93-06E5-4677-B62E-3EC1BF2B488A Q28552284-C451C444-4404-4820-8E3D-5405B604303C Q32177441-4C1A829A-81A9-476A-8F29-8BFE0DDE3437 Q34458291-D3367741-0340-42CB-8F2C-13B0ABABD353 Q34587139-C991008E-01D4-4C10-926D-A7688929162D Q35669596-4AA4BBBA-D55F-48F2-B5D0-FD97E7A6E1C2 Q35675494-DF93A11D-2D4C-4608-B89F-2B15A3726E3A Q35798540-64256DB7-ABE7-41B1-930F-F469C11D520C Q35853333-7988D39D-CD6A-4449-899B-32A9BFD97897 Q35862244-BA7ABE9C-0167-46A7-B066-82955F97EAF9 Q36078092-8F774321-646C-4AC8-9A19-1526B8A051E0 Q36502419-A22AE429-EC86-42AB-8615-C2D5A8D29438 Q36621726-DD80B782-A23B-4F4D-BF24-026DB565640A Q36933281-6730B491-FA7F-4783-84DB-C982EB7E0C30 Q36933398-D5C7F814-A963-48A7-9AF8-8EE6589A16AA Q37091715-BA87A34A-0A5C-464A-8B8E-400BAFEAF54C Q37268884-8C600442-D8D3-45E2-9771-D832C2070AB9 Q37619254-8195B6E8-9C3F-4F36-9C27-2E5E4B1572E6 Q37621004-D29BAEBF-1A3C-4565-AAA3-E867BE4F4FE2 Q37653919-947DB99D-FE49-429F-BD67-B502F4649D5F Q37706796-70B9CC79-8B00-4193-AC8E-B23760CF36DA Q37712185-0B7CC869-51EF-4AA4-971D-1A90B907B9E7 Q38546567-4E934A3E-5C16-4BED-824A-4C367C173A40 Q38681635-BF166FD2-8BC3-4074-B24F-F5DC8327230A Q38866872-4BDBAF40-EA4F-4E26-8707-5905F54F2771 Q38946745-A76158DD-5B6C-4773-AB0F-7D07896D08CB Q39458515-D9E2239E-D6FB-455A-8BCD-9178EDA0971D Q39506935-8B597AA3-30DB-4F63-95EA-F66E93B61CA0 Q39566737-B7A22C43-A2E8-4C40-B02A-A10D461B2D6B Q40051127-297EA9F2-7BDC-4AF7-A544-012CDD8E88DA Q40094165-CC11D012-85BB-45EF-B7B4-D8B89E72D674 Q41906245-9E3E5D6F-BCEA-44D9-9284-28A64CEFF546 Q41948216-D9F3A467-381C-4BCE-A8B2-600B1685060A Q42355202-507C86BF-5656-4BF9-9E10-3E1C1FC35569 Q42722312-455547A3-D532-48AC-86D8-FC3A8E9FFAE9

P2860

Comparison of methods for evaluating drug-drug interaction.

http://www.wikidata.org/entity/Q33914266

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Comparison of methods for evaluating drug-drug interaction.

@ast

Comparison of methods for evaluating drug-drug interaction.

@en

type

label

Comparison of methods for evaluating drug-drug interaction.

@ast

Comparison of methods for evaluating drug-drug interaction.

@en

prefLabel

Comparison of methods for evaluating drug-drug interaction.

@ast

Comparison of methods for evaluating drug-drug interaction.

@en

P1433

Q33914266-99A37577-C80F-4E3C-B7E7-4F5B868C7515

P1476

Q33914266-8E95AC1D-58A7-481F-BFD6-F42760241F22

P2093

Q33914266-95ECCE24-9BDA-407C-A6CC-0197F334EC46

Q33914266-E9BF25FC-6B85-4269-AD25-6A93375BB668

Q33914266-FF64CF6C-1FBA-4D71-81B3-F295B2549EE4

P2860

Q33914266-110688C4-E7CB-4553-9B05-89CCE7CB2321

Q33914266-194A211A-D2EF-40A3-B37F-4C3E42ABFE90

Q33914266-1CCC4D6E-7B50-4B89-8BEF-31C51730B256

Q33914266-7A7325C3-DCFE-48C0-96A6-01F4A796902A

Q33914266-84467526-5D83-4A1D-9943-5BD89B7DC521

Q33914266-B3B2E0C4-07E6-4B64-AF30-00D40F780C15

Q33914266-C98AE570-2704-4900-A1D7-0388D09E54EA

Q33914266-D5843076-069C-4CC6-A45B-942888B558D9

Q33914266-D657C0B6-A88D-44EE-A2AA-ADB29750B14A

Q33914266-DAD0A414-AFFA-404A-830C-00A28F65B9E1

P304

Q33914266-4C2CE3BA-55F2-498C-825C-99108D48AAC9

P31

Q33914266-DE6744C8-5CE1-40D7-9493-B0B02117841C

P356

Q33914266-D993D6B9-DEF0-435B-920F-2BB6DF43C85E

P478

Q33914266-E8768235-8734-485D-9574-9B9ECFC9AB42

P577

Q33914266-C25DB1B5-BB91-49B6-81C3-A40A83BFA7E1

P698

Q33914266-398265B5-4F6A-417B-8AF8-586E297904A5

P932

Q33914266-1C13594D-4438-41FA-BABC-53467492174B

P356

P1433

Frontiers in Bioscience

P1476

Comparison of methods for evaluating drug-drug interaction.

@en

P2093

Jessie L-S Au

http://www.w3.org/2001/XMLSchema#string

Liang Zhao

http://www.w3.org/2001/XMLSchema#string

M Guillaume Wientjes

http://www.w3.org/2001/XMLSchema#string

P2860

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

Mechanism-based pharmacokinetic-pharmacodynamic modeling: biophase distribution, receptor theory, and dynamical systems analysis.

What is synergy?

The search for synergy: a critical review from a response surface perspective.

A new nonlinear mixture response surface paradigm for the study of synergism: a three drug example.

Response surface model for anesthetic drug interactions.

Synergy determination issues.

Evaluation of combination chemotherapy: integration of nonlinear regression, curve shift, isobologram, and combination index analyses.

Lecture on the Antagonism between the Actions of Active Substances.

Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-beta-D-arabinofuranosylcytosine.

P304

241-249

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2741/E86

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20036874

http://www.w3.org/2001/XMLSchema#string

P932

2885905

http://www.w3.org/2001/XMLSchema#string